市場調査レポート
商品コード
1410780
神経調節装置市場:市場規模(セグメント別)、シェア、規制、償還、手技、予測(~2033年)Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
神経調節装置市場:市場規模(セグメント別)、シェア、規制、償還、手技、予測(~2033年) |
出版日: 2023年12月08日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
高齢化社会に影響を及ぼす神経疾患の有病率が高いため、この巨大な高齢者人口基盤が神経調節装置市場の大きな促進要因となっています。このセグメントには、深部脳刺激装置(DBS)、脊髄刺激装置(SCS)、迷走神経刺激装置(VNS)、仙骨神経刺激装置(SNS)、胃電気刺激装置(GES)、末梢神経刺激装置(PNS)などがあります。
当レポートは、世界の神経調節装置市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Neuromodulation Devices market for the year 2020 and beyond. Due to the large prevalence of neurological conditions impacting the aging population, this huge geriatric population base is a large driver of the neuromodulation market. Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS), Gastric Electric Stimulators (GES), Peripheral Nerve Stimulators (PNS) and Leads are tracked under this segment.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Neuromodulation Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, LivaNova Plc, Nevro Corp, SunMed Holdings LLC, Beijing Pins Medical Co Ltd, Curonix Inc, Laborie Medical Technologies Inc, Bioness Inc, Avanos Medical Inc, IntraPace Inc, B. Braun Melsungen AG, Axonics Inc, NeuroPace Inc, Xavant Technology (Pty) Ltd, ReShape Lifesciences Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable